科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/13 | 3,870 | 3,870 | 3,809 | 3,841 | -41 | -1.1% | 136,300 |
| 2024/08/09 | 3,930 | 3,930 | 3,795 | 3,882 | +22 | +0.6% | 156,100 |
| 2024/08/08 | 3,705 | 3,899 | 3,676 | 3,860 | +15 | +0.4% | 295,400 |
| 2024/08/07 | 3,742 | 4,099 | 3,725 | 3,845 | +64 | +1.7% | 333,200 |
| 2024/08/06 | 3,794 | 3,803 | 3,706 | 3,781 | +197 | +5.5% | 232,500 |
| 2024/08/05 | 3,750 | 3,813 | 3,554 | 3,584 | -261 | -6.8% | 338,500 |
| 2024/08/02 | 3,955 | 3,967 | 3,812 | 3,845 | -169 | -4.2% | 177,900 |
| 2024/08/01 | 4,073 | 4,079 | 3,997 | 4,014 | -71 | -1.7% | 123,500 |
| 2024/07/31 | 4,082 | 4,111 | 4,037 | 4,085 | +43 | +1.1% | 343,400 |
| 2024/07/30 | 4,099 | 4,117 | 4,026 | 4,042 | -34 | -0.8% | 118,300 |
| 2024/07/29 | 4,097 | 4,125 | 4,072 | 4,076 | +11 | +0.3% | 86,800 |
| 2024/07/26 | 4,061 | 4,093 | 4,033 | 4,065 | +14 | +0.3% | 112,300 |
| 2024/07/25 | 4,000 | 4,063 | 3,981 | 4,051 | +30 | +0.7% | 122,100 |
| 2024/07/24 | 4,038 | 4,081 | 4,013 | 4,021 | -7 | -0.2% | 85,500 |
| 2024/07/23 | 4,010 | 4,038 | 3,980 | 4,028 | -10 | -0.2% | 120,300 |
| 2024/07/22 | 4,116 | 4,117 | 4,023 | 4,038 | -57 | -1.4% | 102,800 |
| 2024/07/19 | 4,157 | 4,157 | 4,059 | 4,095 | -91 | -2.2% | 146,400 |
| 2024/07/18 | 4,102 | 4,217 | 4,088 | 4,186 | +112 | +2.7% | 235,500 |
| 2024/07/17 | 4,086 | 4,111 | 4,074 | 4,074 | -5 | -0.1% | 103,100 |
| 2024/07/16 | 4,100 | 4,149 | 4,075 | 4,079 | +21 | +0.5% | 149,000 |
| 2024/07/12 | 3,995 | 4,073 | 3,995 | 4,058 | +46 | +1.1% | 137,700 |
| 2024/07/11 | 3,980 | 4,013 | 3,977 | 4,012 | +52 | +1.3% | 99,700 |
| 2024/07/10 | 3,967 | 3,987 | 3,940 | 3,960 | +1 | ±0% | 125,600 |
| 2024/07/09 | 3,950 | 3,994 | 3,950 | 3,959 | +15 | +0.4% | 107,600 |
| 2024/07/08 | 3,950 | 4,059 | 3,929 | 3,944 | +16 | +0.4% | 207,700 |
| 2024/07/05 | 3,899 | 3,928 | 3,883 | 3,928 | +42 | +1.1% | 114,300 |
| 2024/07/04 | 3,863 | 3,922 | 3,850 | 3,886 | +22 | +0.6% | 114,700 |
| 2024/07/03 | 3,817 | 3,878 | 3,802 | 3,864 | +43 | +1.1% | 120,100 |
| 2024/07/02 | 3,854 | 3,866 | 3,809 | 3,821 | -34 | -0.9% | 133,900 |
| 2024/07/01 | 3,845 | 3,900 | 3,842 | 3,855 | +5 | +0.1% | 147,800 |
| 2024/06/28 | 3,858 | 3,879 | 3,811 | 3,850 | +4 | +0.1% | 165,900 |
| 2024/06/27 | 3,830 | 3,881 | 3,811 | 3,846 | +22 | +0.6% | 210,900 |
| 2024/06/26 | 3,798 | 3,829 | 3,786 | 3,824 | +24 | +0.6% | 111,200 |
| 2024/06/25 | 3,800 | 3,830 | 3,794 | 3,800 | +9 | +0.2% | 86,400 |
| 2024/06/24 | 3,779 | 3,812 | 3,778 | 3,791 | +13 | +0.3% | 137,000 |
| 2024/06/21 | 3,796 | 3,829 | 3,775 | 3,778 | -21 | -0.6% | 225,500 |
| 2024/06/20 | 3,772 | 3,810 | 3,765 | 3,799 | +5 | +0.1% | 158,300 |
| 2024/06/19 | 3,712 | 3,838 | 3,712 | 3,794 | +74 | +2% | 179,000 |
| 2024/06/18 | 3,754 | 3,764 | 3,716 | 3,720 | -36 | -1% | 82,300 |
| 2024/06/17 | 3,767 | 3,780 | 3,715 | 3,756 | -9 | -0.2% | 129,500 |
| 2024/06/14 | 3,720 | 3,769 | 3,716 | 3,765 | +32 | +0.9% | 138,600 |
| 2024/06/13 | 3,784 | 3,784 | 3,725 | 3,733 | -57 | -1.5% | 96,600 |
| 2024/06/12 | 3,823 | 3,826 | 3,790 | 3,790 | -1 | ±0% | 102,700 |
| 2024/06/11 | 3,810 | 3,820 | 3,791 | 3,791 | -15 | -0.4% | 73,400 |
| 2024/06/10 | 3,795 | 3,823 | 3,770 | 3,806 | -17 | -0.4% | 119,000 |
| 2024/06/07 | 3,824 | 3,842 | 3,806 | 3,823 | -20 | -0.5% | 171,200 |
| 2024/06/06 | 3,925 | 3,985 | 3,821 | 3,843 | -12 | -0.3% | 363,000 |
| 2024/06/05 | 3,722 | 3,855 | 3,693 | 3,855 | +94 | +2.5% | 455,000 |
| 2024/06/04 | 3,788 | 3,827 | 3,636 | 3,761 | -27 | -0.7% | 555,500 |
| 2024/06/03 | 3,667 | 3,874 | 3,646 | 3,788 | +213 | +6% | 662,700 |
201～
250
件表示中 / 3717件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 385,100円 | -6.4% | -71.8% | 4.93% | 42.89倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 635,000円 | +7.1% | -35.0% | 0.00% | 52.51倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.45倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 208,200円 | +3.1% | -6.5% | 2.31% | 9.66倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
